Hideaki Takahashi

8PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.

|May 20, 2026
Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer.

|Mar 20, 2026
History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma.

Mitsuhiko Katoh, Kohtaro Eguchi, Tatsuya Ito

|Feb 01, 2025
Clinicopathological Significance of Extranodal Extension in Hypopharyngeal and Laryngeal Squamous Cell Carcinoma.

Natsumi Kijima, Yui Uzawa, Yuri Hirai

|May 15, 2023
Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma.

Jun Aoyama, Yusuke Nojima, Daisuke Sano

|Mar 30, 2022
The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.

Kimihide Kusafuka, Yoko Sato, Eiji Nakatani

Pageof 2

Frequent Collaborators

2 joint publications

Yuichiro Tada

2 joint publications

Daisuke Sano

2 joint publications

Kohtaro Eguchi

2 joint publications

Seiichi Yoshimoto